首页>
外国专利>
pharmaceutical compositions with ability to induce apoptosis in cancer cells for the diagnosis and treatment of chronic lymphocytic leukemia b cell
pharmaceutical compositions with ability to induce apoptosis in cancer cells for the diagnosis and treatment of chronic lymphocytic leukemia b cell
展开▼
机译:具有诱导癌细胞凋亡的能力的药物组合物,用于诊断和治疗慢性淋巴细胞性b细胞
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention is related to the branch of immunology and particularly with the generation of pharmaceutical compositions comprising a humanized monoclonal antibody recognizing the leukocyte differentiation antigen CD6. Accordingly with that statement, the purpose of this invention is to provide pharmaceutical compositions comprising a humanized anti-CD6 monoclonal antibody for the diagnosis and treatment of Lymphoproliferative Syndromes and particularly the B-Cell Chronic Lymphocytic Leukemia. The essence of the invention consist in the application of a humanized Monoclonal Antibody that recognizes the CD6 antigen, the generation of pharmaceutical compositions comprising that antibody being able to induce apoptosis of malignant cells from B-Cell Chronic Lymphocytic Leukemia patients, reaching a clinical and a histological antitumor efficacy. The field of application of the present invention extends to the Oncology.
展开▼